GENX — Genex Pharmaceutical Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Genex Pharmaceutical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2003 December 31st	2004 December 31st	2005 December 31st	C2006 December 31st	2007 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10KSB	10KSB	10KSB	10KSB	10KSB
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	0.451	1.01	0.625	0.619	0.343
Depreciation
Non-Cash Items	—	0	0.025	0.006	0.603
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-1.07	-0.983	0.666	0.5	-0.472
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Payable / Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Cash from Operating Activities	-0.601	0.089	1.38	1.18	0.53
Capital Expenditures	-0.305	-0.006	-0.001	-0.004	-0.001
Purchase of Fixed Assets
Other Investing Cash Flow Items	—	—	—	-1.29	-1.88
Other Investing Cash Flow
Cash from Investing Activities	-0.305	-0.006	-0.001	-1.3	-1.88
Financing Cash Flow Items	—	0	-1.42	0.006	1.57
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Cash from Financing Activities	1.15	0	-1.42	0.006	1.57
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	0.242	0.084	-0.03	-0.104	0.238